Global Prostate Cancer Therapeutics Market to 2020

Published on March 2017 | Categories: Documents | Downloads: 35 | Comments: 0 | Views: 373
of 14
Download PDF   Embed   Report

Comments

Content

Renub Research
www.renub.com
Global Prostate Cancer Therapeutics Market to 2020

Published: November, 2015
© Renub Research

Page 1 of 14

Copyright © 2015 Renub Research – All Rights Reserved

Global Prostate Cancer Therapeutics Market Overview
The prostate cancer drugs market is expected to nearly double by 2020, due to the
introduction of new, more expensive drugs. Prostate Cancer is the most frequently diagnosed
cancer in men. In terms of loss of life from any disease, prostate cancer ranks eleventh; and it
ranks sixth in terms of cancer–related mortality in men. The prostate cancer market has a huge
demand for new and novel drugs that address unmet needs such as improved survival time, less
toxicity, increased progression free survival, increased effectiveness, and lower cost. The
global market for the prostate cancer therapeutics market is increasing, driven primarily by
the growth in the hormone–refractory prostate cancer therapeutics market. Although, the
prostate cancer market faces some hindrances such as the high cost of prostate cancer drugs,
the market for prostate cancer drugs is likely to rise in the future.
Global Prostate Cancer Drugs Analysis: Zytiga was the leading prostate cancer drugs in 2014
being followed by Xtandi drugs. In prostate cancer drugs market, Leuplin and Zoladex stand at
the third and fourth position respectively in 2014, while Lupron stands at the fifth position in
the same year. Bayer's cancer drug Xofigo is also increasing its market share. Decapeptyl,
Taxotere, Jevtana and Provenge are the other popular prostate cancer drugs in the global
market.
Renub Research report titled “Global Prostate Cancer Therapeutics Market to 2020”
provides a comprehensive assessment of the fast–evolving, high–growth of Prostate Cancer
Therapeutics Market. This 80 page report with 35 Figures and 2 Tables analyses the Prostate
Cancer Therapy Drugs Market, driving factors and challenges for prostate cancer market
landscape.
The report covers the following:

1. Global Prostate Cancer – Hormonal Therapy Drugs Market


Luteinizing Hormone–Releasing Hormone (LHRH) Antagonists
1. Zytiga

© Renub Research

Page 2 of 14

2. Gonax



Luteinizing Hormone–Releasing Hormone (LHRH) Analogs
1. Lupron
2. Zoladex
3. Decapeptyl
4. Eligard
5. Vantas
6. Leuplin



Anti–Androgens
1. Casodex
2. Xtandi or MDV3100
3. Xtandi US or MDV3100

2. Global Prostate Cancer Chemotherapy Drugs Market
1. Taxotere
2. Jevtana

3. Global Prostate Cancer Immunotherapy Drugs Market
1. Provenge

4. Global Prostate Cancer Targeted Therapy Drugs Market
1. Xofigo or Alpharadin

© Renub Research

Page 3 of 14

Data Sources
This report is built using data and information sourced from proprietary databases, primary and
secondary research and in–house analysis by Renub Research team of industry experts.
Primary sources include industry surveys and telephone interviews with industry experts.
Secondary sources information and data has been collected from various printable and non–
printable sources like search engines, News websites, Government Websites, Trade Journals,
White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books,
Industry Portals, Industry Associations and access to more than 500 paid databases.

© Renub Research

Page 4 of 14

About Us
Renub Research

is a leading Market Research and Information Analysis Company with

centers at Noida India and Roswell USA. We have long–term experience especially in
international Business–to–Business Researches, Surveys, Business and Consulting. Throughout
the years we have acquired expertise in most market sectors, including Information Technology
(IT), Telecoms, Life Sciences, Medical & Pharmaceuticals, Financial Services (Banking,
Insurance, Reinsurance, M&A, etc.), Energy, Chemicals, Automotive, Retail, FMCG, Consumer
Goods, Logistics, Governmental, Social, and Others.
Our core team is comprised of an experienced people holding graduate, post graduate and
Ph.D. degrees in Finance, Marketing, Human Resource, Bio–Technology, Medicine, Information
Technology, Environmental Science and many more. Our research help make the business
decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We
support many blue chip companies by providing them findings and perspectives across a wide
range of markets. Our research reports offer a blend of information insight, analysis and
forecasting that is essential in today’s ultra–competitive markets.

For more information on us or to view any of our sample work you can mail
us at [email protected]

© Renub Research

Page 5 of 14

Published
By

Renub Research
1st Floor,
C – 86, Sector – 10
Noida – 201301
Phone: +91–120–421–9822, 254–5750 (India)
+1–678–302–0700 (USA)
Fax : +91–120–424–9780
Email: [email protected]
www.renub.com

© Global Prostate Cancer Therapeutics Market to 2020
Renub Research, 2015
Edition 1.0
All rights reserved. This publication is protected
by copyright. No part of it may be reproduced, stored
in a retrieval system or transmitted, in any form or by
any means, electronic mechanical, photocopying,
recording or otherwise without the prior written
permission of the publishers

© Renub Research

Page 6 of 14

Table of Contents
1.

Executive Summary

2.

Prostate Cancer – Overview
2.1

Prostate Cancer Introduction

2.2

Risk Factors

2.2.1

Age

2.2.2

Race

2.2.3

Family History/Genetics

2.2.4

Diet/Lifestyle Factors

2.2.5

Obesity

2.2.6

Infection/Inflammation of the Prostate Gland

2.3

Disease Symptoms

2.4

Diagnosis

2.4.1

Digital Rectal Exam (DRE)

2.4.2

Prostate Specific Antigen (PSA) Blood Test

2.4.3

Prostate Ultrasound and Biopsy

2.4.4

Bone Scan

2.4.5

CT Scan & MRI

2.4.6

PET & SPECT Scan

2.4.7

Lymph Node Biopsy

2.4.8

ProstaScint Scan

2.5

Stages of Prostate Cancer

2.5.1

Stage I

2.5.2

Stage II

2.5.3

Stage III

2.5.4

Stage IV

3.

Global Prostate Cancer Drugs Market

4.

Global Prostate Cancer Incidence

© Renub Research

Page 7 of 14

5.

Global Prostate Cancer Drugs Market Share

6.

Global Prostate Cancer – Hormonal Therapy Drugs Sales & Forecast to 2020
6.1

Luteinizing Hormone – Releasing Hormone (LHRH) Antagonists

6.1.1

Zytiga

6.1.2

Gonax / Firmagon

6.2

Luteinizing Hormone – Releasing Hormone (LHRH) Analogs

6.2.1

Lupron

6.2.2

Zoladex

6.2.3

Decapeptyl

6.2.4

Eligard

6.2.5

Vantas

6.2.6

Leuplin

6.3

Anti – Androgens

6.3.1

Casodex

6.3.2

Xtandi or MDV3100

6.3.3

Xtandi US or MDV3100

Global Prostate Cancer – Chemotherapy Drugs Market

7.

7.1

Taxotere

7.2

Jevtana

Global Prostate Cancer – Immunotherapy Drugs Market

8.

8.1

Provenge

Global Prostate Cancer – Targeted Therapy Drugs Market

9.

9.1

10.

Xofigo or Alpharadin

Global Prostate Cancer Market – Driving Factors

10.1

Introduction of Innovative Drugs

10.2

Advancement in Oncology Therapeutic Area

10.3

Development in Genomics & Proteomics

© Renub Research

Page 8 of 14

11.

Global Prostate Cancer Market – Challenges

11.1

Costly Prostate Cancer Drugs

11.2

Adverse Events of Treatment

11.3

Low Success Rate for Oncology Drugs

© Renub Research

Page 9 of 14

List of Figures:
Figure 3–1: Global – Prostate Cancer Drugs Market (Million US$), 2010 – 2014
Figure 3–2: Global – Forecast for Prostate Cancer Drugs Market (Million US$), 2015 – 2020
Figure 4–1: Global – Prostate Cancer Incidence (Number), 2007 – 2014
Figure 4–2: Global – Forecast for Prostate Cancer Incidence (Number), 2015 – 2020

Figure 6–1: Global – Zytiga Drugs Sales (Million US$), 2011 – 2014
Figure 6–2: Global – Forecast for Zytiga Drugs Sales (Million US$), 2015 – 2020
Figure 6–3: Global – Gonax/ Firmagon Drugs Sales (Million US$), 2012 – 2014
Figure 6–4: Global – Forecast for Gonax Drugs Sales (Million US$), 2015 – 2020
Figure 6–5: Global – Lupron Drugs Sales (Million US$), 2009 – 2014
Figure 6–6: Global – Forecast for Lupron Drugs Sales (Million US$), 2015 – 2020
Figure 6–7: Global – Zoladex Drugs Sales (Million US$), 2009 – 2014
Figure 6–8: Global – Forecast for Zoladex Drugs Sales (Million US$), 2015 – 2020
Figure 6–9: Global – Decapeptyl Drugs Sales (Million US$), 2009 – 2014
Figure 6–10: Global – Forecast for Decapeptyl Drugs Sales (Million US$), 2015 – 2020
Figure 6–11: Global – Eligard Drug Sales (Million US$), 2009 – 2014
Figure 6–12: Global – Forecast for Eligard Drug Sales (Million US$), 2015 – 2020
Figure 6–13: Global – Vantas Drugs Sales (Million US$), 2009 – 2014
Figure 6–14: Global – Forecast for Vantas Drugs Sales (Million US$), 2015 – 2020
Figure 6–15: Global – Leuplin Drugs Sales (Million US$), 2009 – 2014
Figure 6–16: Global – Forecast for Leuplin Drugs Sales (Million US$), 2015 – 2020
Figure 6–17: Global – Casodex Drug Sales (Million US$), 2009 – 2014
Figure 6–18: Global – Forecast for Casodex Drug Sales (Million US$), 2015 – 2020
Figure 6–19: Global – Xtandi or MDV3100 Drug Sales (Million US$), 2012 – 2014
Figure 6–20: Global – Forecast for Xtandi or MDV3100 Drug Sales (Million US$), 2015 – 2020
Figure 6–21: Global – Xtandi US or MDV3100 Drug Sales (Million US$), 2012 – 2014
Figure 6–22: Global – Forecast for Xtandi US or MDV3100 Drug Sales (Million US$), 2015 – 2020

Figure 7–1: Global – Taxotere Drug Sales (Million US$), 2011 – 2014
Figure 7–2: Global – Forecast for Taxotere Drug Sales (Million US$), 2015 – 2020
Figure 7–3: Global – Jevtana Drug Sales (Million US$), 2010 – 2014
Figure 7–4: Global – Forecast for Jevtana Drug Sales (Million US$), 2015 – 2020

Figure 8–1: Global – Provenge Drugs Sales (Million US$), 2011 – 2014
© Renub Research

Page 10 of 14

Figure 8–2: Global – Forecast for Provenge Drugs Sales (Million US$), 2015 – 2020

Figure 9–1: Global – Xofigo or Alpharadin Drug Sales (Million US$), 2013 – 2014
Figure 9–2: Global – Forecast for Xofigo or Alpharadin Drug Sales (Million US$), 2015 – 2020
Figure 11–1: Therapeutic Categories – Overall Success Rate from Phase 1 through Likelihood of Approval
(Percent), 2004 – 2010

List of Tables:
Table 5–1: Global – Prostate Cancer Drugs Market Share (Percent), 2011 – 2014
Table 5–2: Global – Forecast for Prostate Cancer Drugs Market Share (Percent), 2015 – 2020

© Renub Research

Page 11 of 14

Order Form
Scan and e-mail this page to [email protected], alternatively one can also write the Contact
Information in an e-mail and mail it. Else you can also fax this form to +91-120-424-9780
Questions? Please call

+91-120-421-9822 (India),

+1-678-302-0700

(USA)

or

mail

[email protected]

Format
1.

Report Title: Global Prostate Cancer Therapeutics Market to 2020

Single User
(Email from Publisher)
US$ 1200

Hard Copy
(Mail Delivery)
US$ 1300

CD – Rom
(Mail Delivery)
US$ 1300

Global Site License
(Multiple User License)
US$ 1800

For ordering this report: Easy ways to place your order:
1) Order online by Credit Card (Visa, MasterCard, etc.):
http://www.renub.com/global-prostate-cancer-therapeutics-market-to-2020-487-p.php

© Renub Research

Page 12 of 14

to

Bank Details
Account Name: Renub Research
A/C No.: 109102000023296
Name of Bank: IDBI Bank Ltd.
Swift Code: IBKLINBB010
Bank Address: 4th Floor
Indian Red Cross Building
1 Red Cross Road
Opposite Parliament Street
New Delhi – 110001
India

Contact Information
First Name:

Last Name:

Email:
Job Title:
Company:
Address:
City:
Postal/Zip Code:
Country:
Phone:
Mobile:
Fax:
Report Format:
Your message:

© Renub Research

Page 13 of 14

3) Order by Check
Please post the check accompanied by this form, to:
Company Address: Renub Research
1st Floor
C-86, Sector -10
Noida - 201301
Uttar Pradesh
India
Phone: +91-120-421-9822, 424-9780

For free Sample copy report or to view any of our sample work please contact us at
[email protected] or call +91-120-421-9822 (India), +1-678-302-0700 (USA)

Follow Us
Facebook: https://www.facebook.com/RenubResearch
LinkedIn: https://www.linkedin.com/company/renub-research
Twitter: https://twitter.com/renubresearch

© Renub Research

Page 14 of 14

Sponsor Documents

Or use your account on DocShare.tips

Hide

Forgot your password?

Or register your new account on DocShare.tips

Hide

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close